SCOPUS 정보 검색 플랫폼

Cancer Chemotherapy and Pharmacology

Volumn 46, Issue 3, 2000, Pages 204-210

Pretreatment with ranitidine does not reduce the bioavailability of orally administered topotecan

(6) Akhtar, Saad a Beckman, Robert A b Mould, Diane R b Doyle, Edward b Fields, Scott Z b Wright, Jonathan a

a University Hospital (United States)

b GLAXOSMITHKLINE (United Kingdom)

Author keywords

Camptothecin; DNA topoisomerase I; Drug interactions; Pharmacokinetics; Topotecan

Indexed keywords

CAMPTOTHECIN; RANITIDINE; TOPOTECAN;

ABDOMINAL PAIN; ADULT; AGED; ALOPECIA; ANOREXIA; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DEPRESSION; DIARRHEA; DNA REPLICATION; DYSPNEA; FATIGUE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOLID TUMOR; VOMITING;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RANITIDINE; TOPOTECAN;

EID: 0033797807 PISSN: 03445704 EISSN: None Source Type: Journal
DOI: 10.1007/s002800000141 Document Type: Article

Times cited : (10)

References (26)

1
- 0032425604
- Topotecan: A new topoisomerase I inhibiting antineoplastic agent
- (1998) Ann Pharmacother , vol.32 , pp. 1334-1343
- Cersosimo, R.J.¹

2
- 0018155445
- Critical evaluation of the potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level time curve
- (1978) J Pharmacokinet Biopharm , vol.6 , pp. 539-547
- Chiou, W.L.¹

3
- 0031848174
- Pharmacokinetic drug interactions with anti-ulcer drugs
- (1998) Clin Pharmacokinet , vol.35 , pp. 135-150
- Dal Negro, R.¹

4
- 0030728122
- The pharmacokinetics of topotecan and its carboxylate form following separate intravenous administration to the dog
- (1997) Pharm Res , vol.14 , pp. 1461-1465
- Davies, B.E.¹ Minthorn, E.A.² Dennis, M.J.³ Rosing, H.⁴ Beijnen, J.H.⁵

5
- 0031062384
- An overview of the clinical pharmacology of topotecan
- (1997) Semin Oncol , vol.24 , Issue.SUPPL. 5
- Dennis, M.J.¹ Beijnen, J.H.² Grochow, L.B.³ Van Warmerdam, L.J.C.⁴

6
- 15444361370
- Oral topotecan given once or twice daily for ten days: A phase 1 pharmacology study in adult patients with solid tumors
- (1998) Clin Cancer Res , vol.4 , pp. 1153-1158
- Gerrits, C.J.¹ Burris, H.² Schellens, J.H.³ Eckardt, J.R.⁴ Planting, A.S.⁵ Van der Burg, M.E.⁶ Rodriguez, G.I.⁷ Loos, W.J.⁸ Van Beurden, V.⁹ Hudson, I.¹⁰ Fields, S.¹¹ Von Hoff, D.D.¹² Verweij, J.¹³

7
- 0032101820
- Five days of oral topotecan (Hycamtin), a phase I and pharmacological study in adult patients with solid tumours
- (1998) Eur J Cancer , vol.34 , pp. 1030-1035
- Gerrits, C.J.¹ Burris, H.² Schellens, J.H.³ Planting, A.S.⁴ Van den Burg, M.E.⁵ Rodriguez, G.I.⁶ Van Beurden, V.⁷ Loos, W.J.⁸ Hudson, I.⁹ Fields, S.¹⁰ Verweij, J.¹¹ Von Hoff, D.D.¹²

8
- 0025332058
- A distribution-free procedure for the statistical analysis of bioequivalence studies
- (1990) Int J Clin Pharmacol Ther Tox , vol.28 , pp. 72-78
- Hauschke, D.¹ Steinijans, V.W.² Diletti, E.³

9
- 0029947777
- Clinical pharmacokinetics of topotecan
- (1996) Clin Pharmacokinet , vol.31 , pp. 85-102
- Herben, V.M.M.¹ Ten Bokkel Huinink, W.W.² Beijnen, J.H.³

10
- 0031823914
- Clinical pharmacokinetics of camptothecin topoisomerase I inhibitors
- (1998) Pharm World Sci , vol.20 , pp. 161-172
- Herben, V.M.M.¹ Ten Bokkel Huinink, W.W.² Schellens, J.H.M.³ Beijnen, J.H.⁴

11
- 0032589190
- Oral topotecan: Bioavailability and effect of food co-administration
- (1999) Br J Cancer , vol.80 , pp. 1380-1386
- Herben, V.M.M.¹ Rosing, H.² Huinink, W.W.T.³ Van Zomeren, D.M.⁴ Batchelor, D.⁵ Doyle, E.⁶ Beusenberg, F.B.⁷ Beijnen, J.H.⁸ Schellens, J.H.M.⁹

12
- 0031714683
- Clinical pharmacology of camptothecins
- (1998) Cancer Chemother Pharmacol , vol.42 , Issue.SUPPL.
- Iyer, L.¹ Ratain, M.J.²

13
- 0025733635
- The drug interaction potential of ranitidine: An update
- (1991) Pharmacol Ther , vol.50 , pp. 233-244
- Klotz, U.¹ Kroemer, H.K.²

14
- 0007754917
- Reference deleted

15
- 0033010638
- 2-receptor antagonists
- (1999) Clin Pharmacol Ther , vol.65 , pp. 369-376
- Martinez, C.¹ Albet, C.² Agundez, J.A.G.³ Herrero, E.⁴ Carillo, J.A.⁵ Marquez, M.⁶ Benitez, J.⁷ Ortiz, J.A.⁸

16
- 0029966916
- Phase I and pharmacologic study of topotecan in patients with impaired renal function
- (1996) J Clin Oncol , vol.14 , pp. 3062-3073
- O'Reilly, S.¹ Rowinsky, E.K.² Slichenmyer, W.³ Donehower, R.C.⁴ Forastiere, A.A.⁵ Ettinger, D.S.⁶ Chen, T.L.⁷ Sartorius, S.⁸ Grochow, L.B.⁹

17
- 0029034767
- High-performance liquid chromatographic determination of the novel antitumour drug topotecan and topotecan as the total of the lactone plus carboxylate forms, in human plasma
- (1995) J Chromatogr B Biomed Sci Appl , vol.668 , pp. 107-115
- Rosing, H.¹ Doyle, E.² Davies, B.E.³ Beijnen, J.H.⁴

18
- 0031016943
- Isolation and structural confirmation of N-desmethyl-topotecan, a metabolite of topotecan
- (1997) Cancer Chemother Pharmacol , vol.39 , pp. 498-504
- Rosing, H.¹ Herben, V.M.M.² Van Gortel-van Zomeren, D.M.³ Hop, E.⁴ Kettenes-van den Bosch, J.J.⁵ Ten Bokkel Huinink, W.W.⁶ Beijnen, J.H.⁷

19
- 0031679901
- O-glucuronidation, a newly identified metabolic pathway for topotecan and N-desmethyl-topotecan
- (1998) Anticancer Drugs , vol.9 , pp. 587-592
- Rosing, H.¹ Van Zomeren, D.M.² Doyle, E.³ Bult, A.⁴ Beijnen, J.H.⁵

20
- 0007853848
- SAS/STAT user's guide, version 6 (4th edn), vols 1 and 2. SAS Institute, Cary, NC
- (1990)

21
- 0029973829
- Bio-availability and pharmacokinetics of oral topotecan: A new topoisomerase I inhibitor
- (1996) Br J Cancer , vol.73 , pp. 1268-1271
- Schellens, J.H.M.¹ Creemers, G.J.² Beijnen, J.H.³ Rosing, H.⁴ De Boer-Dennert, M.⁵ McDonald, M.⁶ Davies, B.⁷ Verweij, J.⁸

22
- 0029790139
- Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: An Eastern Cooperative Oncology Group trial
- (1996) J Clin Oncol , vol.14 , pp. 2345-2352
- Schiller, J.H.¹ Kim, K.M.² Hutson, P.³ DeVore, R.⁴ Glick, J.⁵ Stewart, J.⁶ Johnson, D.⁷

23
- 0021189178
- Interactions affecting drug absorption
- (1984) Clin Pharmacokinet , vol.9 , pp. 404-434
- Welling, P.G.¹

24
- 0029825085
- Effects of food on drug absorption
- (1996) Annu Rev Nutr , vol.16 , pp. 383-415
- Welling, P.G.¹

25
- 0024374412
- The effects of food on drug bioavailability
- (1989) Br J Clin Pharmacol , vol.28 , pp. 621-628
- Winstanley, P.A.¹ Orme, L.'E.²

26
- 15444358162
- Probenecid alters topotecan systemic and renal disposition by inhibiting renal tubular secretion
- (1998) J Pharmacol Exp Ther , vol.284 , pp. 89-94
- Zamboni, W.C.¹ Houghton, P.J.² Johnson, R.K.³ Hulstein, J.L.⁴ Crom, W.R.⁵ Cheshire, P.J.⁶ Hanna, S.K.⁷ Richmond, L.B.⁸ Luo, X.⁹ Stewart, C.F.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.